Table 1.
Relationship between task features and neurobiology implicated in decision-making assays involving an assessment of uncertaintya
| Task type | Task feature present |
Neurobiology implicated in risky choice |
|||||
|---|---|---|---|---|---|---|---|
| Loss | Contingency shift | Utility matched | BLA | lOFC | mPFC | DA | |
| rIGT | ✓ | ![]() |
![]() |
? | —b | ? | ? |
| rGT | ✓ | ![]() |
![]() |
↑ | — | ↓ |
c
|
| RDT | ✓ | ✓ | ![]() |
↑ | ↓ | ? | ✓ |
| PDT | ![]() |
✓ | ![]() |
↓ | — | ↑↓d | ✓ |
| rBT | ![]() |
✓ | ✓ | — | ↑ | — | ✓ |
a Symbols are used to indicate whether risky choice is increased (↑), decreased (↓), or unaffected (—) by inactivation or silencing of the BLA, lateral OFC, or regions of the mPFC. The last column provides a somewhat crude overview of whether DA plays a strong role in mediating choice, based on the effects of acute or chronic pharmacological challenges with specific dopaminergic agents (i.e., not just psychostimulants, which can act on a multitude of neurochemical signaling systems).
b This is inferred from cFos staining, rather than inactivation/lesion experiments.
c The cued version of the rGT is sensitive to D3 receptor agonists and antagonists.
d The presence of both upward and downward arrows signifies that risky choice can be both increased and decreased by targeting different DA receptor subtypes, particularly in frontal cortex, such that a simple linear relationship between DA tone and risky choice is unlikely.
